Orange County Business Journal Feature: “GATC Creates Insurance Coverage for Clinical Trials”

IRVINE, Calif., August 6, 2024 — The Orange County Business Journal featured GATC Health Corp in a recent article, "GATC Creates Insurance Coverage for Clinical Trials." With a weekly circulation of over 60 thousand executives in Orange County, CA, where GATC is headquartered, the article highlights the company's partnership with Lloyd's of London syndicate Medical & Commercial International Limited (MCI) to create the first program to insure clinical trial outcomes, effectively de-risking investments in drug development.

The article notes other company achievements, including the recent investment of $5 million by the West Virginia Economic Development Authority and West Virginia Jobs Investment Trust to help with staffing and build-out of lab space adjacent to West Virginia University. It also discusses the recent milestones achieved at University of California, Irvine, in validating a very high degree of efficacy in treating fentanyl-addicted rats with GATC's Opioid Use Disorder drug candidate. The study results are expected to be published in a major peer-reviewed journal in coming months.

From the article:

"Since our founding, GATC Health has been focused on changing the way drugs are discovered, disease is predicted and human health is improved, harnessing the power of our proprietary AI,” Chief Executive John Stroh told the Business Journal. “GATC’s platform is making drug development more accurate, faster and safer."

Read the full article here.

About GATC Health
GATC Health Corp is a technology company revolutionizing disease prediction and drug discovery and development through its transformative AI platform and approach, which de-risks drug pipelines and accelerates new therapies to treat disease with accuracy, efficiency and speed never before achieved in medical science. The company’s validated and proprietary Multiomics Advanced Technology™ (MAT) platform simulates human biochemistry’s billions of interactions for accurate and rapid disease prediction, novel target identification, and drug discovery and development. GATC envisions the future of medicine now, where health is protected, disease is reversed and every person’s unique biology is treated with precision.